Professional Documents
Culture Documents
Farmako B.inggris
Farmako B.inggris
Update Policies
The most difficult and time-consuming element of ensuring access to uterotonic druge is
changing policeis, standrads and guideline to align them with best practies. Chainging these
policeis, standards and guidelines can be approadched using two-step process: 1) advocate
whit evidence for addressing the problem, and 2) create an enabling policy environment.
Advocate With Evidence For Addressing The Problem
The first step in the process will involve informing policy makers and giving them an
evidence base with which to make decisions about changing policy. Useful acvities include,
but are not limited to :
Develop Champions For PPH Prevention And Treatment
To ensure that PPH is on national agenda, it is helpful to have champions at the national level
who are conviced of the evidence and can persuasively advocate to decision-makers for PPH
interventions. Key governmet officials, members of professional associations,pre-service and
in-service educations progams and influential clinicians can be powerful champions.
Demonstrate That PPH Is A Public Health Priority
Hemorrhage is a leading direct cause of maternal deaths in the word. 1
PPH is preventable through use of simple interventions that should be offered to all
women at the time of birth
PPH is treatable-but requires rapid recognitions and care to prevent life-threatening
consequences. A woman can die for PPH in just 2 hours.
PPH is unpredictable, so every pregnant woman care during chidbirth from an SBA.
Yet, in developing countries, two-thirds of deliveries occur at home without an SBA.
Woman giving birth at home without a skilled provider are at increased risk of dying
from complications, including PPH.
The selection of a rational mix of uterotonic drugs for prevention and treatment of PPH is
essential of ensuring access to lifesaving interventions. This document, while not exhaustive,
has attempted to guide policymakers, pharmacy managers, and ministries of health through
the procces of choosing uterotonic drugs for each type of birth attendent and at each point of
care. Once strategy for distribution of uterotonic drugs has been established, it is essential to
link it with logistics systems to ensure that quantification, procurement, supply chain
management and quality assurance of uterotonic drugs are integrated with drug procurement
systems.
5. Memperbarui Kebijakan
Unsur yang paling sulit dan memakan waktu untuk memastikan akses terhadap obat
uterotonik adalah mengubah kebijakan, standar dan pedoman untuk menyesuaikannya dengan
praktik terbaik. Memuaskan peraturan, standar, dan pedoman kebijakan ini dapat diatasi
dengan menggunakan proses dua langkah: 1. Mengadvokasi sedikitpun bukti untuk
mengatasi masalah tersebut, 2. Membuat lingkungan kebijakan yang memungkinkan.
Pemilihan campuran rasional obat uterotonik untuk pencegahan dan pengobatan PPH
sangat penting untuk memastikan akses terhadap intervensi menyelamatkan nyawa. Dokumen
ini, walaupun tidak lengkap, telah berusaha untuk membimbing para pembuat kebijakan,
manajer farmasi, dan kementerian kesehatan melalui proses pemilihan obat-obatan uterotonik
untuk setiap jenis kelahiran dan pada setiap titik perawatan. Setelah strategi untuk distribusi
obat uterotonik telah ditetapkan, sangat penting untuk menghubungkannya dengan sistem
logistik untuk memastikan bahwa kuantifikasi, pengadaan, manajemen rantai pasokan dan
jaminan kualitas obat-obatan uterotonik terintegrasi dengan sistem pengadaan obat.